FDA Inspection 572094 — Glaxo Wellcome Manufacturing Pte Limited
The FDA completed an inspection of Glaxo Wellcome Manufacturing Pte Limited on Mar 13, 2009 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singapore (Singapore)